O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.37M
AUM Growth
-$123K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
153
New
Increased
Reduced
Closed

Top Buys

1
+$110K
2
+$99.3K
3
+$50.1K
4
TMO icon
Thermo Fisher Scientific
TMO
+$45K
5
BLU
BELLUS Health Inc.
BLU
+$33.6K

Top Sells

1
+$168K
2
+$151K
3
+$108K
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$82.9K
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$65.3K

Sector Composition

1 Healthcare 98.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
– –
-200,000
127
– –
-1,370,250
128
– –
-23,600
129
– –
-2,044,000
130
– –
-2,012,250
131
– –
-1,964,770
132
– –
-57,100
133
– –
-112,700
134
– –
-2,124,975
135
– –
-1,667,693
136
– –
-287,600
137
– –
-131,100
138
– –
0
139
– –
-1,817,521
140
– –
0
141
– –
-22,200
142
– –
-447,376
143
– –
-723,478
144
– –
-425,286
145
– –
-1,361,400
146
– –
-538,500
147
– –
0
148
– –
-900,000
149
– –
-2,108,555
2 3 4 5
6